The “Defibrillation Testing, Why Not?” survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice

International Journal of Cardiology: Heart & Vasculature

卷:38

Stefano Viani¹  Erika Taravelli²  Sergio Valsecchi³  Giovanni Luca Botto³  Alessandro Vicentini⁴  Mariolina Lovecchio⁵  Valter Bianchi⁶  Federico Migliore⁷  Paolo De Filippo⁸  Valeria Ilia Calvi⁹  Luca Ottaviano¹⁰  Pietro Francia¹¹  Gianfranco Tola¹²  Matteo Ziacchi¹³  Silvana De Bonis¹⁴ 

[1] Corresponding author at: Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via N. Giustiniani 2, 35121 Padova, Italy.;

[2] Arrhythmia and Electrophysiology and Experimental Cardiology, IRCCS Fondazione Policlinico 'S. Matteo', Pavia, Italy;

[3] Boston Scientific, Milan, Italy;

[4] Cardiology Division, A.O. 'Brotzu', Cagliari, Italy;

[5] Cardiology Division, Policlinico “G. Rodolico - San Marco”, Catania, Italy;

[6] Cardiology, Department of Clinical and Molecular Medicine, Sapienza University, St. Andrea Hospital, Rome, Italy;

[7] Department of Cardiac, Thoracic Vascular Sciences and Public Health University of Padova, Italy;

[8] Division of Cardiology, Castrovillari Hospital, Cosenza, Italy;

[9] Division of Cardiology, “Maggiore” Hospital of Crema, Cremona, Italy;

[10] Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Policlinico S.Orsola-Malpighi, Bologna, Italy;

[11] Istituto Clinico Sant'Ambrogio, Milan, Italy;

[12] Papa Giovanni XXIII Hospital, Bergamo, Italy;

[13] Second Cardiology Division, Cardio-Thoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy;

[14] “Unità Operativa di Elettrofisiologia, Studio e Terapia delle Aritmie”, Monaldi Hospital, Naples, Italy;

关键词: Implantable defibrillator;    Subcutaneous;    Defibrillation testing;    Survey;   

DOI  :  

来源: DOAJ

【 摘 要 】

Background: Defibrillation testing (DT) can be omitted in patients undergoing transvenous implantable cardioverter–defibrillator (T-ICD) implantation, but it is still recommended for patients at risk for a high defibrillation threshold and for ICD generator changes. Moreover, DT is still recommended on implantation of subcutaneous ICD (S-ICD). The aim of the present survey was to analyze the current practice of DT during T-ICD and S-ICD implantations. Methods: In March 2021, an ad hoc questionnaire on the current performance of DT and the standard practice adopted during testing was completed at 72 Italian centers implanting S-ICD and T-ICD. Results: 48 (67%) operators reported never performing DT during de-novo T-ICD implantations, while no operators perform it systematically. The remaining respondents perform it for patients at risk for a high defibrillation threshold. DT is never performed at T-ICD generator change. At the time of de-novo S-ICD implantation, DT is never performed by 9 (13%) operators and performed systematically by 48 (66%). The remaining operators frequently omit DT in patients with more severe systolic dysfunction. DT is not performed at S-ICD generator change by 92% of operators. DT is conducted by delivering a first shock energy of 65 J by 60% of operators, while the remaining 40% test lower energy values. Conclusions: In current clinical practice, most operators omit DT at T-ICD implantation, even when still recommended in the guidelines. DT is also frequently omitted at S-ICD implantation, and a wide variability exists among operators in the procedures followed during DT.

【 授权许可】

Unknown